Navigation Links
A new gene silencing platform -- silence is golden
Date:2/8/2009

NEW BRUNSWICK, N.J. A team of researchers led by Rutgers' Samuel Gunderson has developed a novel gene silencing platform with very significant improvements over existing RNAi approaches. This may enable the development and discovery of a new class of drugs to treat a wide array of diseases. Critical to the technology is the approach this team took to specifically target RNA biosynthesis.

The research findings are reported in the journal Nature Biotechnology, published online in the February 8th issue.

Gunderson, an associate professor in the Department of Molecular Biology and Biochemistry at Rutgers, The State University of New Jersey, has created highly efficient gene silencing agents that function via a novel mechanism of action. The agents are single-stranded oligonucleotides, called U1 Adaptors, that have dual, and independent, functions. First is a target-gene binding domain that can be tailored to any gene. The second domain inhibits mRNA maturation by binding U1 snRNP, a component of the cellular splicing apparatus.

By combining both capabilities in the same molecule, the U1 Adaptor can inhibit the pre-mRNA maturation step of polyA tail addition in a gene specific manner. Further, the domains of the oligonucleotide are independent so transcript binding and U1 snRNP binding can be independently optimized and adapted to a wide array of genes associated with disease.

"The U1 Adaptor platform expands on early technologies that used 5'-end-mutated U1 snRNA," Gunderson explained. "The U1 Adaptor is an oligonucleotide version of this older method and instead targets the 3' end processing step. U1 Adaptors have high activity when used alone and are synergistic when used in combination with RNAi." Gunderson went on to say that the range of possible targets is very broad due to the mechanism of action in which inhibition occurs during the biosynthesis of mRNA at the near universal 3' end processing step. Perhaps the most
'/>"/>

Contact: Thomas Richardson
richardson@ocltt.rutgers.edu
Rutgers University
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. In lung cancer, silencing one crucial gene disrupts normal functioning of genome
2. Researchers solve piece of large-scale gene silencing mystery
3. New gene-silencing pathway found in plants
4. Cold Spring Harbor Protocols highlights gene silencing, cancer cell biology methods
5. Class of antibiotics can enhance gene-silencing tool
6. WCC Announces Version 6 of its ELISE Smart Search and Match Platform for Employment and Biometric Matching
7. CIC Teams With Industry Leader iPipeline to Provide Electronic Signature Platform to the Nations Top Insurance Carriers
8. Full-Featured Video Analytics Platform Available in Smart Camera Format
9. Mount Sinai researchers discover technology that silences genes
10. Computation and genomics data drive bacterial research into new golden age
11. PET/CT imaging proves golden for detecting cancer in children

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., PHILADELPHIA Less acculturated Latino men ha...se who are more acculturated to U.S. culture, but ...tting smoking. Details of these findings are publi...ion , a journal of the American Association for Ca...cus on tobacco. , "Acculturation affects smoking...
(Date:12/2/2009)..., , PHILADELPHIA People who smoke their first ci...igher levels of cotinine, a by-product of nicotine...o smoke, regardless of the number of cigarettes sm...ect the risk of lung cancer, our results suggest t... be especially at risk for lung cancer," said rese...
(Date:12/2/2009)... PHILADELPHIA Assurance of a cancer-free status d...computerized tomography (CT) lung-cancer screening...chers wrote in a study published in Cancer Epidem... American Association for Cancer Research. The Dec..., These findings should negate widespread concern...
Breaking Biology News(10 mins):Acculturation affects smoking cessation success among Latinos 2Increased nicotine levels detected in those who light-up earlier 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Second hand smoking results in liver disease study finds 9877 1Second hand smoking results in liver disease study finds 9877 2Ritter Pharmaceuticals Hires Dr Howard Foyt as Executive Vice President Development 26 Chief Medical Officer 56849 1Ritter Pharmaceuticals Hires Dr Howard Foyt as Executive Vice President Development 26 Chief Medical Officer 56849 2ADA FDI World Dental Federation Observe World Oral Health Day 56846 1ADA FDI World Dental Federation Observe World Oral Health Day 56846 2
...07 In a paper published today in the journal Scie... and academic colleagues from the National Univers...n Sweden report the discovery of two common single...uman genome that appear to account for virtually a...are located in the LOXL1 gene on chromosome 15, an...
...cer therapy by blocking the molecular motors invol...ision is being pursued by young Dutch researcher D...inning projects sponsored by the European Science ...h Councils (EuroHORCS). Dekker and her team are t...h the molecular motors that copy DNA during cell d...
..., researchers report for the first time that genet...ures harboring DNA that are inherited only from th...or type 2 diabetes. The study, which highlights t...athogenesis of common diseases, is published onlin...rding to the Centers for Disease Control, 7% of th...
Other Biology News:deCODE discovers cause of major subtype of glaucoma 2ESF EURYI award winner aims to stop cancer cells reading their own DNA 2Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes 2
(Date:12/2/2009)...Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech...SDAQ: ONCY ) announced today that in connection wi...erwriters have exercised in full their over-allotm...ts. Each unit is comprised of one common share and...old at a price of US$3.00 per unit. Each whole com...
(Date:12/2/2009)...ALEM, Israel, December 2 Gamida Ce...the preclinical (animal study) safety and,efficacy...gy from Weill,Cornell Medical College and Gamida C...ited anemias such as Cooley,s Anemia. , G...to expand, ex vivo,populations of stem/progenitor...
(Date:12/2/2009).... 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc....bal biopharmaceutical company focused on endocrine...S. Food and Drug Administration (FDA) has granted ...pathway inhibitor compound, perifosine (KRX-0401),... myeloma. Keryx Biopharmaceuticals, Inc. ("Keryx")...
(Date:12/1/2009).... Kerry Solomon announced that he has joined Carol...gned website at www.DrKerrySolomon.com , which wa...mon is a proven LASIK, lens implant, and cataract ...zed for his substantial contributions to improving...sted LASIK Surgeons, which screens LASIK surgeons ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
... VALLEY COTTAGE, N.Y., Feb. 5 XTL,Biopharmaceutic...ed notification,that on February 3, 2009 the Compa...ore than 5% of the Company,s outstanding ordinary ...y shareholders, meeting (EGM) of the Company as,so...g matters: , 1. that Boaz Shweiger be and is h...
... TOKYO, February 5 HOYA Corporation today,announc...ecember 31, 2008.,Net sales were 112.7 billion yen... from 147.0 billion yen in the third quarter of 20...he product price resulting from global,economic do...ctro-Optics and,Vision Care, as well as PENTAX tha...
... CHAPEL HILL, N.C., Feb. 5 In today,s tough econo...y, even while focusing on,strategy and tactics to ...etter understand the resources dedicated by biopha...ons, a recent benchmark study was conducted by Bes...ewly published report,"Benchmarks for Optimizing M...
Other Biology Technology:XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter 2Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008 2New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth 2
...internal standard for the quantification of 5-OxoE...-OxoETE is a polyunsaturated keto acid formed by t...imulates cytosolic calcium levels in neutrophils w...es the migration and degranulation of eosinophils ...
...0 kb Autographa californica (AcNPV) polyhedrin loc...NPV polyhedrin promoter and two AcNPV p10 promoter... cloning site, followed by polyhedrin locus-derive...rted polyhedrin promoter has been inserted contain...
...Delivers 4,600 to Over 3 Million Genotypes Per Day...ble of performing 4,600 to over 3 Million genotype...s*, this automated, scalable, multiplexed system c...d 384-well plate, for cost-effective high throughp...
Mouse Anti-HD Monoclonal Antibody, Unconjugated, Clone 3D6 from Abnova Corporation
Biology Products: